Open access
Aug 2026
A plasma‐based protein signature combining NPTXR, ACHE, and p‐tau217 predicts progression to symptomatic Alzheimer's disease
We recently identified a plasma‐based seven‐protein model with strong performance for Alzheimer's disease (AD) classification. Here, we evaluated whether these proteins, alone or combined with plasma phosphorylated tau 217 (p‐tau217), predict progression from cognitively unimpaired to symptomatic AD.
Menghan Liu, Katherine Gong, Yike Chen et al.
· Alzheimer's & Dementia · 0 citations